Sei Investments Co. Buys 10,574 Shares of Maximus, Inc. $MMS

Sei Investments Co. lifted its stake in Maximus, Inc. (NYSE:MMSFree Report) by 12.7% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 93,826 shares of the health services provider’s stock after purchasing an additional 10,574 shares during the period. Sei Investments Co. owned 0.18% of Maximus worth $6,014,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of MMS. Norges Bank bought a new position in Maximus in the 4th quarter valued at $60,393,000. River Road Asset Management LLC raised its position in shares of Maximus by 236.1% during the fourth quarter. River Road Asset Management LLC now owns 823,262 shares of the health services provider’s stock worth $71,064,000 after acquiring an additional 578,326 shares during the last quarter. Goldman Sachs Group Inc. lifted its stake in shares of Maximus by 218.4% during the fourth quarter. Goldman Sachs Group Inc. now owns 583,627 shares of the health services provider’s stock valued at $50,379,000 after acquiring an additional 400,315 shares during the period. Boston Partners lifted its stake in shares of Maximus by 47.0% during the third quarter. Boston Partners now owns 966,139 shares of the health services provider’s stock valued at $88,236,000 after acquiring an additional 308,892 shares during the period. Finally, The Manufacturers Life Insurance Company boosted its holdings in Maximus by 493.0% in the fourth quarter. The Manufacturers Life Insurance Company now owns 342,266 shares of the health services provider’s stock valued at $29,544,000 after acquiring an additional 284,548 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

Maximus Trading Up 3.2%

NYSE MMS opened at $62.16 on Tuesday. The stock has a 50-day simple moving average of $58.70 and a 200 day simple moving average of $68.28. The company has a market capitalization of $3.27 billion, a PE ratio of 9.30 and a beta of 0.60. The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.87. Maximus, Inc. has a 12 month low of $52.73 and a 12 month high of $100.00.

Maximus (NYSE:MMSGet Free Report) last released its earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.98 by $0.09. The firm had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.32 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The company’s quarterly revenue was down 4.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.01 earnings per share. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Research analysts forecast that Maximus, Inc. will post 8.43 EPS for the current year.

Maximus Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be paid a dividend of $0.33 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.32 annualized dividend and a yield of 2.1%. Maximus’s dividend payout ratio (DPR) is presently 19.76%.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on MMS shares. Weiss Ratings lowered Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Zacks Research downgraded shares of Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Finally, Wall Street Zen upgraded shares of Maximus from a “hold” rating to a “buy” rating in a research report on Saturday, June 6th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company has an average rating of “Hold”.

View Our Latest Report on Maximus

Maximus Profile

(Free Report)

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

Featured Articles

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.